Publications

Pubmed logo      Google Scholar

Select Publications

  1. Katchman BA, Barderas R, Alam R, Chowell D, Field MS, Esserman LJ, Wallstrom G, LaBaer J, Cramer D, Hollingsworth MA, Anderson KSProteomic Mapping of p53 Immunogenicity in Pancreatic, Ovarian, and Breast Cancers. Proteomics Clin Appl. 2016 Apr 28. doi: 10.1002/prca.201500096. [Epub ahead of print]

  2. Ewaisha R, Meshay I, Resnik J, Katchman BA, Anderson KSProgrammable protein arrays for immunoprofiling HPV-associated cancers.Proteomics. 2016 Apr;16(8):1215-24. doi: 10.1002/pmic.201500376. Epub 2016 Apr 4.

  3. Krishna S, Anderson KS.T-Cell Epitope Discovery for Therapeutic Cancer Vaccines. Methods Mol Biol. 2016;1403:779-96. doi: 10.1007/978-1-4939-3387-7_45.

  4. Ewaisha R, Anderson KSProteomic Monitoring of B Cell Immunity. Methods Mol Biol. 2016;1403:131-52. doi: 10.1007/978-1-4939-3387-7_6.

  5. Meyer PA, Socias S, Key J, Ransey E, Tjon EC, Buschiazzo A, Lei M, Botka C, Withrow J, Neau D, Rajashankar K, Anderson KS, Baxter RH, Blacklow SC, Boggon TJ, Bonvin AM, Borek D, Brett TJ, Caflisch A, Chang CI, Chazin WJ, Corbett KD, Cosgrove MS, Crosson S, Dhe-Paganon S, Di Cera E, Drennan CL, Eck MJ, Eichman BF, Fan QR, Ferré-D'Amaré AR, Christopher Fromme J, Garcia KC, Gaudet R, Gong P, Harrison SC, Heldwein EE, Jia Z, Keenan RJ, Kruse AC, Kvansakul M, McLellan JS, Modis Y, Nam Y, Otwinowski Z, Pai EF, Pereira PJ, Petosa C, Raman CS, Rapoport TA, Roll-Mecak A, Rosen MK, Rudenko G, Schlessinger J, Schwartz TU, Shamoo Y, Sondermann H, Tao YJ, Tolia NH, Tsodikov OV, Westover KD, Wu H, Foster I, Fraser JS, Maia FR, Gonen T, Kirchhausen T, Diederichs K, Crosas M, Sliz P. Data publication with the structural biology data grid supports live analysis. Nat Commun. 2016 Mar 7;7:10882. doi: 10.1038/ncomms10882.

  6. Ewaisha R, Gawryletz CD, Anderson KSCrucial considerations for pipelines to validate circulating biomarkers for breast cancer. Expert Rev Proteomics. 2016;13(2):201-11. doi: 10.1586/14789450.2016.1132170. Epub 2016 Jan 4.

  7. Chowell D, Krishna S, Becker P, Cocita, Cocita, C, Shu J, Tan X, Greenberg P, Klavinskis L, Blattman J, Anderson KS.  TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopes, PNAS 2015: 1500973112v1-21500973. http://www.pnas.org/content/early/2015/03/20/1500973112.abstract

  8. Chowell D, Castillo-Chavez C, Krishna S, Qiu X, Anderson KS. Modelling the effect of early detection of Ebola, Lancet Infect Dis. 2015 Feb; 15(2): 148-49.


2014

  1. Marks Jr, Anderson KS, Engstrom P, Godwin AK, Esserman LJ, Longton G, Iversen ES, Mathew A, Patriotis C, Pepe MS. Construction and Analysis of the NCI-EDRN Breast Cancer Reference Set for Circulating Markers of Disease, Cancer Epidemiol Biomarkers Prev.2014 Dec 3; 24(2);1-7.

  2. Anderson KS, Cramer DW, Sibani S, Wallstrom G, Wong J, Park J, Qiu J, Vitonis A, LaBaer J. An autoantibody signature for the serologic detection of ovarian cancer, Journal Proteome Research. 2014 Nov 3:578-586 PMID 25365139

  3. Zeng W, Su M, Anderson KS, Sasada T, Artificial antigen-presenting cells expressing CD80, CD70, and 4-1BB ligand efficiently expand functional T cells specific to tumor-associated antigens, Immunobiology. 2014 Aug;219(8):583-92. doi: 10.1016/j.imbio.2014.03.003. Epub 2014 Mar 20.  PMID: 24713579

  4. D’Souza G, Gross N, Pai SI, Haddad R, Anderson KS, Rajan S, Gerber J, Gillison ML, Posner M. Oral human papillomavirus (HPV)-positive oropharyngeal cancer cases and their partners. Journal of Clinical Oncology. 2014 Apr 28. 55.1341. PMID: 24778397.

  5. Siufi Neto J, Kho RM, Siufi DF, Baracat EC, Anderson KS, Abrão MS. J Minim Invasive Gynecol. 2014 Jan-Feb;21(1):55-63. doi: 10.1016/j.jmig.2013.07.021. Epub 2013 Aug 17. Review. PMID: 23962574 Cellular, histologic, and molecular changes associated with endometriosis and ovarian cancer.


2013

  1. Wallstrom G, Anderson KS, LaBaer J. Biomarker Discovery for Heterogeneous Diseases, Cancer Epidemiology, Biomarkers & Prevention. 2013 May;22(5):747-755. PMID: 23462916

  2. Wang J, Barker K, Steel J, Park J, Saul J, Festa F, Wallstrom G, Yu X, Bian X, Anderson KS, Figueroa JD, LaBaer J, Qiu J. Proteomics Clin Appl. 2013 Jun;7(5-6):378-83. doi: 10.1002/prca.201200062. Epub 2013 May 17. A versatile protein microarray platform enabling antibody profiling against denatured proteins.


2011

  1. Anderson KS. Multiplexed Detection of Antibodies using Programmable Bead Arrays. Methods Mol. Biol. 2011, 723:227-38.

  2. Yang C, Hayashida T, Li C, Shen D, Maheswaren S, Chen L, Anderson KS, Sgroi DC,and Schmidt EV.  Dual roles of the integrin αvβ3-5 ligand MFG-E8: Suppressive functions in ER+ and erbB2+ breast cancer and p63/73 target gene in triple negative breast cancers. Cancer Research 2011, 71(3):937-45

  3. Marotta LL, Almendro V, Marusyk A, Shipitsin M, Schemme J, Walker SR, Bloushtain-Qimron N, Kim JJ, Choudhury SA, Maruyama R, Wu Z, Gönen M, Mulvey LA, Bessarabova MO, Huh SJ, Silver SJ, Kim SY, Park SY, Lee HE, Anderson KS, Richardson AL, Nikolskaya T, Nikolsky Y, Liu XS, Root DE, Hahn WC, Frank DA, Polyak K. J Clin Invest. The JAK2/STAT3 signaling pathway is required for growth of CD44CD24 stem cell-like breast cancer cells in human tumors. 2011 Jul;121(7):2723-35. doi: 10.1172/JCI44745.

  4. Chen J, Yu F, Gong C, Yao Y, Deng H, Wang F, Lin L, Su S, Yao H, Su F, Anderson KS, Liu Q, Ewen ME, Yao X, and Song E.  CCL18 from tumor associated macrophages promotes epithelial-mesenchymal transition and metastasis of breast cancer cells via PITPNM3. Cancer Cell, 2011  Apr 12;19(4):541-55.

  5. Anderson KS, Zeng W, Sasada T, Su M, Drakoulakos D, Kang Y-J, Brusic V, Wu C, and Reinherz EL.  Impaired Tumor Antigen Processing by Immunoproteasomes in CD40-Activated B cells and Dendritic Cells. Cancer Immunol. Immunother. 2011, 60: 857-67.

  6. Marotta L, Almendro V, Shipitsin M, Marusyk A, Schemme J, Walker SR, Bloushtain-Qimron N, Kim JJ, Choudhury SA, Maruyama R, Wu Z, Gönen M, Mulvey LA, Bessarabova MO, Huh SJ, Silver SJ, Kim SY, Park SY, Lee HE, Anderson KS, Richardson AL, Nikolskaya T, Nikolsky Y, Liu XS, Root DE, Hahn WC, Frank DA and Polyak K. Specific activation and requirement of Stat3 in CD44+CD24- breast cancer cells.  Journal of Clinical Investigation 2011, 121: 2723-35.

  7. Anderson KS, Wong J,  D’Souza G,  Riemer AB,  Lorch J,  Haddad R,  Pai S,  Longtine J,  Bryan J, McClean M, LaBaer J, Kelsey KT,  and Posner  M. Serum Antibodies to the HPV16 Proteome As Biomarkers For Head and Neck Cancer.  Brit. J. Cancer 2011, 104: 1896-905.

  8. Anderson KS,  Sibani S,  Wallstrom G, Qiu J,  Mendoza E, Raphael, J, Hainsworth E,  Montor W, Wong J,  Lokko N,  Ramachandran N,  Godwin A, Marks J, Engstrom P, and LaBaer J. A Protein Microarray Signature of Autoantibody Biomarkers for the Early Detection of Breast Cancer. J. Proteome Res. 2011 Jan 7;10(1):85-96


2010

  1. Reimer A, Keskin D, Zhang G, Handley M, Anderson KS, Brusic V, Reinhold B, and Reinherz E. A conserved E7-derived CTL epitope expressed on human papillomavirus-16 transformed HLA-A2+ human epithelial cancers.  J.Biol.Chem. 2010. Sep 17;285(38):29608-22.

  2. Anderson KS, Wong J, Vitonis A, Crum CP, Sluss PM, LaBaer J, and Cramer D.  p53 Autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer. Cancer Epi Biomark and Prev, 2010, Mar;19(3):859-68.

  3. Anderson KS, Petersson S, Wong J, Shubbar E, Lokko NN, and Enerback C. Elevation of serum epidermal growth factor  and IL-1 receptor antagonist  in active psoriasis vulgaris. Br J Dermatol. 2010 Nov;163(5):1085-9.


2009

  1. Wong J, Sibani S, Lokko NL, LaBaer J, and Anderson KS. Rapid Detection of Antibodies in Sera using Multiplexed Self-Assembling Bead Arrays.  J Immunol Methods 2009, Oct 31;350(1-2):171-82.

  2. Mirshahidi S, Kramer VG, Whitney JB, Essono S, Lee S, Anderson KS, Dranoff G,and Ruprecht RM. Reduced Tumor Growth and Prolong Survival after Immunization of Mice with Overlapping Synthetic Peptides Covering Tumor Protein D52.  Vaccine. 2009 Mar 13;27(12):1825-33.

  3. Anderson KS, Wong, J, Polyak K, Aronzon D, and Enerback, C.  Detection of Psoriasin/S100A7 in the Sera of Psoriatic Patients.  Br J Dermatol. 2009; Feb;160(2):325;32.


2008

  1. Anderson KS, Ramachandran N, Wong J, Raphael JV, Hainsworth E, Demirkan G, Cramer D, Aronzon D, Hodi FS, Harris L, Logvinenko T, Labaer J.Application of Protein Microarrays for Multiplexed Detection of Antibodies to Tumor Antigens in Breast Cancer. J Proteome Res. 2008 Apr 4;7(4):1490-1499.

  2. Ramachandran N*, Anderson KS*, Raphael JV, Hainsworth E, Sibani S, Montor W, Pacek M, Wong J, Eljanne M, Sanda MG, Hu Y, Logvinenko T, and Labaer J. Tracking Humoral Responses Using Self Assembling Protein Microarrays. Proteomics Clin. Appl. 2008, 2, 1518-1527